244 related articles for article (PubMed ID: 24935925)
21. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.
Majumdar T; Sharma S; Kumar M; Hussain MA; Chauhan N; Kalia I; Sahu AK; Rana VS; Bharti R; Haldar AK; Singh AP; Mazumder S
Cell Death Dis; 2019 Feb; 10(3):161. PubMed ID: 30770800
[TBL] [Abstract][Full Text] [Related]
22. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
Silva NM; Rodrigues CV; Santoro MM; Reis LF; Alvarez-Leite JI; Gazzinelli RT
Infect Immun; 2002 Feb; 70(2):859-68. PubMed ID: 11796621
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
24. Essential involvement of IFN-gamma in Clostridium difficile toxin A-induced enteritis.
Ishida Y; Maegawa T; Kondo T; Kimura A; Iwakura Y; Nakamura S; Mukaida N
J Immunol; 2004 Mar; 172(5):3018-25. PubMed ID: 14978106
[TBL] [Abstract][Full Text] [Related]
25. Malaria parasite induces tryptophan-related immune suppression in mice.
Tetsutani K; To H; Torii M; Hisaeda H; Himeno K
Parasitology; 2007 Jul; 134(Pt 7):923-30. PubMed ID: 17316473
[TBL] [Abstract][Full Text] [Related]
26. The IFN-γ-IDO1-kynureine pathway-induced autophagy in cervical cancer cell promotes phagocytosis of macrophage.
Yang SL; Tan HX; Niu TT; Liu YK; Gu CJ; Li DJ; Li MQ; Wang HY
Int J Biol Sci; 2021; 17(1):339-352. PubMed ID: 33390854
[No Abstract] [Full Text] [Related]
27. Blockade of indoleamine 2,3-dioxygenase reduces mortality from peritonitis and sepsis in mice by regulating functions of CD11b+ peritoneal cells.
Hoshi M; Osawa Y; Ito H; Ohtaki H; Ando T; Takamatsu M; Hara A; Saito K; Seishima M
Infect Immun; 2014 Nov; 82(11):4487-95. PubMed ID: 25114116
[TBL] [Abstract][Full Text] [Related]
28. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
Romani L; Fallarino F; De Luca A; Montagnoli C; D'Angelo C; Zelante T; Vacca C; Bistoni F; Fioretti MC; Grohmann U; Segal BH; Puccetti P
Nature; 2008 Jan; 451(7175):211-5. PubMed ID: 18185592
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis.
Saavedra PHV; Huang L; Ghazavi F; Kourula S; Vanden Berghe T; Takahashi N; Vandenabeele P; Lamkanfi M
Nat Commun; 2018 Nov; 9(1):4846. PubMed ID: 30451870
[TBL] [Abstract][Full Text] [Related]
30. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans.
Kiank C; Zeden JP; Drude S; Domanska G; Fusch G; Otten W; Schuett C
PLoS One; 2010 Jul; 5(7):e11825. PubMed ID: 20689575
[TBL] [Abstract][Full Text] [Related]
31. The Butyrate-Producing Bacterium
Hayashi A; Nagao-Kitamoto H; Kitamoto S; Kim CH; Kamada N
J Immunol; 2021 Apr; 206(7):1576-1585. PubMed ID: 33597149
[TBL] [Abstract][Full Text] [Related]
32. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.
Jasperson LK; Bucher C; Panoskaltsis-Mortari A; Mellor AL; Munn DH; Blazar BR
Blood; 2009 Dec; 114(24):5062-70. PubMed ID: 19828695
[TBL] [Abstract][Full Text] [Related]
33. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
[TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
35. Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii.
Ganesan S; Roy CR
PLoS Pathog; 2019 Aug; 15(8):e1007955. PubMed ID: 31461509
[TBL] [Abstract][Full Text] [Related]
36. Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.
Feunou P; Vanwetswinkel S; Gaudray F; Goldman M; Matthys P; Braun MY
J Immunol; 2007 Jul; 179(2):910-7. PubMed ID: 17617582
[TBL] [Abstract][Full Text] [Related]
37. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
[TBL] [Abstract][Full Text] [Related]
38. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
39. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.
Koblish HK; Hansbury MJ; Bowman KJ; Yang G; Neilan CL; Haley PJ; Burn TC; Waeltz P; Sparks RB; Yue EW; Combs AP; Scherle PA; Vaddi K; Fridman JS
Mol Cancer Ther; 2010 Feb; 9(2):489-98. PubMed ID: 20124451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
